CDx Commercialisation

Pictured: Gabrielle Gucciardo, Senior Scientist
Home /

CDx Commercialisation

When it comes to the discovery, development and commercialisation of companion diagnostics for future precision medicines, no two pharmaceutical or biotech companies will ever have the same needs.

At Almac Diagnostic Services, we understand these needs: timelines can be challenging, platform flexibility may be required, regulatory approaches may vary and clinical studies often require bespoke methodologies.

Our Customised CDx approach has been designed to offer you an intuitive partnership, with a range of flexible options and specialist supporting services, tailored to your specific drug and companion diagnostic development requirements.

Working with companies worldwide, we create and deliver CDx solutions that are unique – helping you to differentiate your drug in the marketplace.

  • Complex Gene Signatures
  • Multiple Disease Areas
  • Platform Agility
  • Global Laboratory Facilities
  • Flexible Commercialisation Models

Interested in starting a Customised CDx Partnership?

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies